Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sunil Krishnan

Showing results (181-190 of 337) with videos related to

Pageof 34
Sort By:
Scientific Reports|July 1, 2020
Author Correction: Ultra high dose rate (35 Gy/sec) radiation does not spare the normal tissue in cardiac and splenic models of lymphopenia and gastrointestinal syndromeBhanu Prasad Venkatesulu, Amrish Sharma, Julianne M Pollard-Larkin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 27, 2005
The optimization of dose delivery for intraoperative high-dose-rate radiation therapy using curved HAM applicatorsA Sam Beddar, Sunil Krishnan, Tina M Briere, et al.
Cancer|December 31, 2009
Long-term quality of life after radiotherapy for the treatment of anal cancerPrajnan Das, Scott B Cantor, Crystal L Parker, et al.
Cancers|May 14, 2020
Clinical Theragnostic Potential of Diverse miRNA Expressions in Prostate Cancer: A Systematic Review and Meta-AnalysisRama Jayaraj, Greg Raymond, Sunil Krishnan, et al.
Scientific Reports|July 11, 2020
Pilot study of neurologic toxicity in mice after proton minibeam therapyJohn G Eley, Awalpreet S Chadha, Caio Quini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 27, 2012
Ursolic acid inhibits growth and metastasis of human colorectal cancer in an orthotopic nude mouse model by targeting multiple cell signaling pathways: chemosensitization with capecitabineSahdeo Prasad, Vivek R Yadav, Bokyung Sung, et al.
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|October 29, 2022
Radiotherapy reimagined: Integrating nanomedicines into radiotherapy clinical trialsAllison N DuRoss, Jack Phan, Alexander J Lazar, et al.
International Journal of Radiation Oncology, Biology, Physics|January 26, 2005
Phase II trial of carmustine, cisplatin, and oral etoposide chemotherapy before radiotherapy for grade 3 astrocytoma (anaplastic astrocytoma): results of North Central Cancer Treatment Group trial 98-72-51Ravi D Rao, Sunil Krishnan, Tom R Fitch, et al.
International Journal of Cancer|September 22, 2011
Zyflamend suppresses growth and sensitizes human pancreatic tumors to gemcitabine in an orthotopic mouse model through modulation of multiple targetsAjaikumar B Kunnumakkara, Bokyung Sung, Jayaraj Ravindran, et al.
Critical Reviews in Oncology/Hematology|February 18, 2019
Corrigendum to "Imaging predictors of treatment outcomes in rectal cancer: An overview" [Crit. Rev. Oncol./Hematol. 129, (September) (2018), 153-162]Lakshmi ShreeMahadevan, James Zhong, BhanuPrasad Venkatesulu, et al.
Pageof 34

Showing results (181-190 of 337) with videos related to

Sort By:
Pageof 34
Scientific Reports|July 1, 2020
Author Correction: Ultra high dose rate (35 Gy/sec) radiation does not spare the normal tissue in cardiac and splenic models of lymphopenia and gastrointestinal syndromeBhanu Prasad Venkatesulu, Amrish Sharma, Julianne M Pollard-Larkin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 27, 2005
The optimization of dose delivery for intraoperative high-dose-rate radiation therapy using curved HAM applicatorsA Sam Beddar, Sunil Krishnan, Tina M Briere, et al.
Cancer|December 31, 2009
Long-term quality of life after radiotherapy for the treatment of anal cancerPrajnan Das, Scott B Cantor, Crystal L Parker, et al.
Cancers|May 14, 2020
Clinical Theragnostic Potential of Diverse miRNA Expressions in Prostate Cancer: A Systematic Review and Meta-AnalysisRama Jayaraj, Greg Raymond, Sunil Krishnan, et al.
Scientific Reports|July 11, 2020
Pilot study of neurologic toxicity in mice after proton minibeam therapyJohn G Eley, Awalpreet S Chadha, Caio Quini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 27, 2012
Ursolic acid inhibits growth and metastasis of human colorectal cancer in an orthotopic nude mouse model by targeting multiple cell signaling pathways: chemosensitization with capecitabineSahdeo Prasad, Vivek R Yadav, Bokyung Sung, et al.
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|October 29, 2022
Radiotherapy reimagined: Integrating nanomedicines into radiotherapy clinical trialsAllison N DuRoss, Jack Phan, Alexander J Lazar, et al.
International Journal of Radiation Oncology, Biology, Physics|January 26, 2005
Phase II trial of carmustine, cisplatin, and oral etoposide chemotherapy before radiotherapy for grade 3 astrocytoma (anaplastic astrocytoma): results of North Central Cancer Treatment Group trial 98-72-51Ravi D Rao, Sunil Krishnan, Tom R Fitch, et al.
International Journal of Cancer|September 22, 2011
Zyflamend suppresses growth and sensitizes human pancreatic tumors to gemcitabine in an orthotopic mouse model through modulation of multiple targetsAjaikumar B Kunnumakkara, Bokyung Sung, Jayaraj Ravindran, et al.
Critical Reviews in Oncology/Hematology|February 18, 2019
Corrigendum to "Imaging predictors of treatment outcomes in rectal cancer: An overview" [Crit. Rev. Oncol./Hematol. 129, (September) (2018), 153-162]Lakshmi ShreeMahadevan, James Zhong, BhanuPrasad Venkatesulu, et al.
Pageof 34